Literature DB >> 1621409

[Peri-graft reaction. A complication after implantation of a prosthesis shunt in children with congenital cyanotic heart defects].

E Feil1, G Arnold, A Borowski, U Mennicken.   

Abstract

Two different clinical manifestations of perigraft-reactions complicating the implantation of prosthetic aortopulmonary shunts in children with cyanotic congenital heart disease are described and discussed. The incidence of this complication in the past 5 years in our own patients was 3%. The appearance of a localized mass on the chest film surrounding the prosthesis requires the exclusion of a hematoma, aneurysm or inflammation. In the case of a massive serous pleural effusion examination of the ingredients leads to diagnosis. Concerning our own patients the fluid is identical with serum; the leakage through the prosthesis can therefore be called plasmapheresis. The claimed pathogenetic causes are discussed intensively, including a chylothorax promoting this complication in the second case. Local variations in porosity and structure of the implanted prosthesis may play a critical role in the pathogenesis of perigraft-reaction, as indicated by both our reported cases. In the event of unsuccessful observation of a localized perigraft seroma or of unsuccessful chest drainage of a massive pleural serous effusion, graft replacement and placement of a different graft material are found to have the best results.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621409

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  2 in total

1.  Spiral CT angiography in an infant with severe hypoplasia of a long segment of the descending aorta.

Authors:  H G Brochhagen; G Benz-Bohm; U Mennicken; S Schickendantz; A Borowski; K J Lackner
Journal:  Pediatr Radiol       Date:  1997-02

2.  Saphenous vein wrapping for the treatment of a perigraft seroma: report of a case.

Authors:  Yildirim Imren; Lawand Qaradaghi; Gursel Levent Oktar; Emrah Ereren; Naim Boran Tumer
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.